Berenberg Bank Analysts Give Fresenius Medical Care AG & Co. (Pref) (FME) a €94.00 Price Target

berenberg-bank-analysts-give-fresenius-medical-care-ag-038-co-pref-fme-a-83649400-price-target.gif

Fresenius Medical Care AG & Co. (Pref) (ETR:FME) has been given a €94.00 ($104.44) price objective by equities researchers at Berenberg Bank in a research note issued on Tuesday. The firm currently has a a “buy” rating on the stock.
Other equities research analysts have also recently issued research reports about the company. Oddo Securities set a €87.00 ($96.67) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Wednesday, April 27th. Sanford C. Bernstein set a €92.00 ($102.22) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Monday, April 18th. Independent Research GmbH set a €95.00 ($105.56) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Monday, April 11th. JPMorgan Chase & Co. set a €105.00 ($116.67) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Friday, April 8th. Finally, Bankhaus Lampe set a €80.00 ($88.89) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Tuesday, May 3rd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have assigned a buy rating to the stock. Fresenius Medical Care AG & Co. (Pref) currently has a consensus rating of “Buy” and an average price target of €88.97 ($98.86).
Fresenius Medical Care AG & Co. (ETR:FME) traded down 1.14% on Tuesday, reaching €78.97. The company had a trading volume of 186 shares. Fresenius Medical Care AG & Co. has a 12 month low of €67.50 and a 12 month high of €85.52. The firm has a 50-day moving average of €81.40 and a 200-day moving average of €77.89. The stock has a market capitalization of €24.14 billion and a P/E ratio of 21.89.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/11/berenberg-bank-analysts-give-fresenius-medical-care-ag-co-pref-fme-a-94-00-price-target-2.html

Fresenius Medical Care AG & Co. (Pref) Company Profile
Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com’s FREE daily email newsletter.

Be the first to comment on "Berenberg Bank Analysts Give Fresenius Medical Care AG & Co. (Pref) (FME) a €94.00 Price Target"

Leave a comment

Your email address will not be published.

*